Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors

Keio University Hospital, Tokyo

Osaka International Cancer Institute, Osaka

Aichi Cancer Center Hospital, Aichi

Akita University Hospital, Akita

Tohoku University Hospital, Aoba-ku

Hirosaki University Hospital, Aomori

Kanagawa Cancer Center, Asahi-ku

Juntendo University Hospital, Bunkyō City

Chiba Cancer Center, Chiba

Chiba Cancer, Chūōku

National Cancer Center Hospital East, Chiba

Nagoya University Hospital, Chūōku

Osaka International Cancer Institute, Chūōku

Shikoku Cancer Center, Ehime

National Hospital Organization Shikoku Cancer Center, Ehime

Hyogo Cancer Center, Hyōgo

Kagawa University Hospital, Kagawa

Tokai University School of Medicine, Kanagawa

The Cancer Institute Hospital of JFCR, Kōtō City

Kumamoto University Hospital, Kumamoto

Kyoto University Hospital, Kyoto

Hiroshima University Hospital, Minamiku

Nara Medical University Hospital, Nara

Hyogo College of Medicine College Hospital, Nishinomiya-shi

Okayama University Hospital, Okayama

Osaka Metropolitan University Hospital, Osaka

Osaka University Hospital, Osaka

Kindai University Hospital, Osaka

Kindai University Hospital, Osakasayama-shi

Saitama Medical University, Saitama

National Hospital Organization Hokkaido Cancer Center, Sapporo

National Center for Global Health and Medicine, Shinjuku-ku

National Cancer Center hospital, Tokyo

Tokyo Medical And Dental University, Medical Hospital, Tokyo

Showa University Hospital, Tokyo

Yamaguchi University Hospital, Yamaguchi